Government

Image description

Janssen Pharmaceuticals gets FDA nod for Invega Sustenna

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

Image description

FDA grants approval to Olysio from Janssen Therapeutics

Janssen Therapeutics announced earlier this week that the Food and Drug Administration approved Olysio (simeprevir), a hepatitis C virus NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen. 

Image description

NACDS: 2014 elections represent a win for pharmacy

The NACDS-PAC supported a majority of winners in Tuesday's elections, comprising 86% in Senate races and 93% in House races, Steven Anderson, president and CEO of the National Association of Chain Drug Stores, said in a memo released Wednesday.